The broad, long-term objective of this project is to evaluate the therapeutic value of vein of Marshall (VOM) ethanol infusion when added to catheter ablation of atrial fibrillation (AF). AF is the most common sustained arrhythmia in adults, and it is a leading cause of stroke, disability and increased mortality. Catheter ablatin - pulmonary vein (PV) antral isolation (PVAI)- can lead to cure, but is best suited for paroxysmal AF, in which ectopic beats arising from the pulmonary veins were shown to initiate AF. PVAI success is lower in persistent AF, in which the role of the cardiac autonomic system, particularly the intrinsic cardiac ganglia, is being increasingly recognized. Expanding the ablation lesions to include greater areas the left atrial (LA) anatomy marginally improves outcomes, but also leads to increases in procedural complexity and duration, need of repeat procedures, and complications such as atrial flutters, particularly perimitral flutter (PMF). We have developed a technique to perform rapid ablation of atrial tissues in AF using ethanol infusion in the vein of Marshall (VOM), and have shown: 1) Effective, rapid and safe tissue ablation of LA tissue neighboring the LA ridge and left inferior PV;2) Regional LA vagal denervation by reaching the intrinsic cardiac ganglia;and 3) Facilitation of cure of PMF by ablating most of the mitral isthmus. We propose to evaluate outcomes differences yielded by VOM ethanol when added to conventional PVAI.
The specific aims are: #1.To assess the impact of VOM ethanol infusion in procedure success when added to de novo catheter ablation of persistent AF. We will randomize patients with persistent AF undergoing a first AF ablation to standard PVAI vs a combined VOM ethanol infusion plus PVAI (VOM-PV). #2. To assess the impact of VOM ethanol infusion added to repeat catheter ablation of recurrent AF after a failed ablation. Patients undergoing a repeat procedure for persistent AF after a failed PVAI will be randomized to either PVAI or VOM-PV as their repeat procedure. End points will include freedom from symptomatic or electrocardiographic AF after 12-15 months.
Atrial fibrillation is a disorganized heart rhythm that causes stroke and increases death rates. An atrial vein, the vein of Marshall, has nerves that can initiate atrial fibrillation. We have developed a new technique can safely help treat AF by ablating the vein of Marshall and propose to study its role in the treatment of atrial fibrillation.
|Tavares, Liliana; Dave, Amish; Valderrábano, Miguel (2018) Successful ablation of premature ventricular contractions originating from the inferoseptal process of the left ventricle using a coronary sinus approach. HeartRhythm Case Rep 4:371-374|
|Rodríguez-Mañero, Moisés; Kreidieh, Bahij; Al Rifai, Mahmoud et al. (2017) Ablation of Inappropriate Sinus Tachycardia: A Systematic Review of the Literature. JACC Clin Electrophysiol 3:253-265|
|Segura-Ibarra, Victor; Cara, Francisca E; Wu, Suhong et al. (2017) Nanoparticles administered intrapericardially enhance payload myocardial distribution and retention. J Control Release 262:18-27|
|Ibarra-Cortez, Sergio Hugo; Rodríguez-Mañero, Moisés; Kreidieh, Bahij et al. (2016) Strategies for phrenic nerve preservation during ablation of inappropriate sinus tachycardia. Heart Rhythm 13:1238-1245|
|Rodríguez-Mañero, Moisés; Schurmann, Paul; Valderrábano, Miguel (2016) Ligament and vein of Marshall: A therapeutic opportunity in atrial fibrillation. Heart Rhythm 13:593-601|
|Kreidieh, Bahij; Rodríguez-Mañero, Moisés; Schurmann, Paul et al. (2016) Retrograde Coronary Venous Ethanol Infusion for Ablation of Refractory Ventricular Tachycardia. Circ Arrhythm Electrophysiol 9:|
|Dukkipati, Srinivas R; Woollett, Ian; McELDERRY, H Thomas et al. (2015) Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: Results of the U.S. Feasibility Study. J Cardiovasc Electrophysiol 26:944-949|
|Price, Matthew J; Reddy, Vivek Y; Valderrábano, Miguel et al. (2015) Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience. JACC Cardiovasc Interv 8:1925-1932|
|Schurmann, Paul; Peñalver, Jorge; Valderrábano, Miguel (2015) Ethanol for the treatment of cardiac arrhythmias. Curr Opin Cardiol 30:333-43|
|Chaikriangkrai, Kongkiat; Jyothula, Soma; Jhun, Hye Yeon et al. (2015) Incidence, Risk Factors, Prognosis, and Electrophysiological Mechanisms of Atrial Arrhythmias after Lung Transplantation. JACC Clin Electrophysiol 1:296-305|
Showing the most recent 10 out of 20 publications